Menu Close
Professor of Biomedical Engineering, Johns Hopkins University

I did the first experiments showing altered DNA methylation in cancer. I showed that epigenetic changes (chemical changes other than DNA sequence per se) cause cancer are not simply consequential to it through my studies of the disorder Beckwith-Wiedemann syndrome. Later I had the first NIH funded epigenome center. More recently I have developed the idea the genetic variants can control epigenetic stochasticity (plasticity) and phenotype (traits) under evolutionary selection in natural populations, or within an individual in the development of cancer.

Experience

  • –present
    Bloomberg Distinguished Professor, Johns Hopkins University

Education

  • 1976 
    Johns Hopkins University, Medicine